AI assistant
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012
Feb 28, 2012
30583_dirs_2012-02-28_339b1550-0314-4565-a6ce-3d15c245e8e4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-02-24
Reporting Person: Cooper Jeffrey H (SVP, Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-02-24 | Common Stock | M | 4864 | $17.54 | Acquired | 44968 | Direct |
| 2012-02-24 | Common Stock | M | 41964 | $17.33 | Acquired | 86932 | Direct |
| 2012-02-24 | Common Stock | M | 8708 | $17.86 | Acquired | 95640 | Direct |
| 2012-02-24 | Common Stock | M | 2500 | $14.39 | Acquired | 98140 | Direct |
| 2012-02-24 | Common Stock | M | 25000 | $21.51 | Acquired | 123140 | Direct |
| 2012-02-24 | Common Stock | S | 83036 | $35.0690 | Disposed | 40104 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-02-24 | Stock Option (right to buy) Comon Stock | $17.54 | M | 4864 | Disposed | 2016-11-19 | Common Stock (4864) | Direct |
| 2012-02-24 | Stock Option (right to buy) Common Stock | $17.33 | M | 41964 | Disposed | 2017-06-06 | Common Stock (41964) | Direct |
| 2012-02-24 | Stock Option (right to buy) Common Stock | $17.86 | M | 8708 | Disposed | 2018-12-16 | Common Stock (8708) | Direct |
| 2012-02-24 | Stock Option (right to buy) Common Stock | $14.39 | M | 2500 | Disposed | 2019-05-11 | Common Stock (2500) | Direct |
| 2012-02-24 | Stock Option (right to buy) Common Stock | $21.51 | M | 25000 | Disposed | 2020-05-11 | Common Stock (25000) | Direct |
Footnotes
F1: The price in Column 4 is a weighted average price. The prices actually received ranged from $34.88 to $35.29. The reporting person will provide to the issuer, any security holder of the issuer, or SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F2: Original option grant vested 6/48ths on May 20, 2007 and 1/48th on the 12th of every month thereafter.
F3: Original option grant vested 6/48ths on December 7, 2007 and 1/48th on the 12th of every month thereafter.
F4: Original option grant vested 6/48ths on May 17, 2009 and 1/48th on the 12th of every month thereafter.
F5: Original option grant vested 6/48ths on November 12, 2009 and 1/48th on the 12th of every month thereafter.
F6: Original option grant vested 6/48ths on November 12, 2010 and 1/48th on the 12th of every month thereafter.